The Prescription Drug Price Transparency Act (ORS 646A.689) directs the Oregon Department of Consumer and Business Services to establish a transparency program to accept reports and disclose certain information from prescription drug manufacturers, health insurance carriers, and consumers on drug prices.
The goal of the program is to provide accountability for prescription drug pricing through the notice and disclosure of specific drug costs and price information from pharmaceutical manufacturers, health insurers, and consumers.
News and updates
- The Prescription Drug Affordability Board will be formed by the governor and become part of the Department of Consumer and Business Services, as required by
Oregon Senate Bill 844.
- Manufacturers are required to report 60 days in advance of specific price increases as required by Oregon House Bill 2658. See the manufacturer page for more information on this reporting requirement.
- The public is encouraged to submit their stories on how rising prescription drug prices have affected their lives or if they have experienced a price increase to the program.
Share your Rx drug price story